0026-3824 NDC - KOVALTRY (ANTIHEMOPHILIC FACTOR (RECOMBINANT))

Drug Information

Product NDC: 0026-3824

Proprietary Name: Kovaltry

Non Proprietary Name: Antihemophilic Factor (Recombinant)

Active Ingredient(s):


Administration Route(s):

Dosage Form(s): KIT

Labeler Information

Labeler Name: Bayer HealthCare LLC
Product Type: PLASMA DERIVATIVE
FDA Application Number: BLA125574
Marketing Category: BLA
Start Marketing Date:3/17/2016

Package Information

No. Package Code Package Description Billing Unit
10026-3824-251 KIT in 1 BOX (0026-3824-25) * 2.5 mL in 1 VIAL, SINGLE-USE (0026-4824-01) * 2.5 mL in 1 SYRINGE (0026-0426-02)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC0026-3824The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEPLASMA DERIVATIVEIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEKovaltryThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAntihemophilic Factor (Recombinant)The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEKITThe translation of the dosage form Code submitted by the firm.
START MARKETING DATE3/17/2016This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEBLAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERBLA125574This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEBayer HealthCare LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 8/16/2019